Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.083% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) Cc1ccc(C)n1-c1ccc(C(=O)NCc2cccnc2)cc1
(b) O=C(CSCc1ccc(Cl)cc1)N/N=C/c1c(Cl)cccc1Cl
(c) Cn1c(SCc2nnc3n2CCCCC3)nc2ccccc21
Answer: c. Cn1c(SCc2nnc3n2CCCCC3)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(SCc2nnc3n2CCCCC3)nc2ccccc21
Cn1c(SCc2nnc3n2CCCCC3)nc2ccccc21
3-[(1-methylbenzimidazol-2-yl)sulfanylmethyl]-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine